Skip to main content
. 2023 Jun 9;39:103451. doi: 10.1016/j.nicl.2023.103451

Table 1.

Demographics of schizophrenia patients and healthy control subjects.

Characteristics SZ (N = 203) HC (N = 201) t/χ2 p value
Age, mean (SD), year 31.897±9.139 31.294±8.703 0.677 0.499
Sex, male/female 108/96 105/97 0.038 0.846
Educational level 47.065 < 0.001
(Unfinished) primary school 20 7
Middle school 32 73
High school 46 53
Junior college 60 27
University 45 29
Postgraduate 11 1
Duration of illness, mean ± SD, year 7.029±6.227 (n = 203) a
PANSS scores, mean ± SD
Total score 92.683±13.825 (n = 162)
Positive symptoms 24.469±6.240 (n = 162)
Negative symptoms 25.080±5.999 (n = 162)
General psychopathology symptoms 43.025±8.558 (n = 162)
MCCB scores, mean ± SD
Trail Making, Part A 69.096±36.472 (n = 188)
BACS symbol coding 37.946±13.121 (n = 186)
Category fluency 14.982±6.265 (n = 188)
HVLT-R 16.218±6.552 (n = 189)
WMS-III spatial span 11.550±3.734 (n = 182)
NAB mazes 8.473±6.486 (n = 182)
BVMT-R 16.945±10.395 (n = 188)
CPT-IP 1.348±0.772 (n = 169)

Note: PANSS = Positive and Negative Syndrome Scale; SD = standard deviation; MCCB = MATRICS Consensus Cognitive Battery; BACS = Brief Assessment of Cognition in Schizophrenia; WMS-III = Wechsler Memory Scale, Third Edition; NAB = Neuropsychological Assessment Battery; HVLT-R = Hopkins Verbal Learning Test-Revised; BVMT-R = Brief Visuospatial Memory Test-Revised; CPT-IP = Continuous Performance Test-Identical Pairs. a Different n are due to missing values on one or more tests for some subjects.